Hon ANDREW LITTLE (Minister of Health): The Government recently secured access to two new pharmaceutical drugs for treating COVID-19—Ronapreve and baricitinib. Baricitinib is the fifth drug Pharmac has secured and sits alongside remdesivir, tocilizumab, molnupiravir, and Ronapreve as treatments doctors can turn to to help people with a range of COVID-19 symptoms. The addition of new drugs to the suite of COVID-19 medicines is good news for patients and for the health system as they help to reduce the severity of symptoms, cut time in hospital, and reduce the likelihood of death. All of these treatments are in addition to vaccination, which, of course, remains the best protection against COVID-19.